A Longitudinal, Multi-Center Safety Study of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears

Enrolling by invitation · Not applicable

Conditions studied: Partial Thickness Rotator Cuff Tear

In brief

This is a longitudinal follow-up study of the RC-002 study, in which up to 246 subjects assigned to two randomization arms will be enrolled: an adipose-derived regenerative cell (ADRC) injection arm (ADRC treatment arm) and the SOC corticosteroid injection arm (active control arm). All subjects will be randomly assigned to ADRC treatment or active control arms in a 2:1 ratio and will be followed up for 6 months. The goal of the RC-004 study is to enroll all patients that were enrolled and treated in RC-002 and follow for 3 years.

Key facts

Study ID: NCT05400798
Run by: InGeneron, Inc.
People needed: 246
Starts: 2022-01-01
Expected to finish: 2025-12-30
Last updated by the study team: 2025-08-17

Who can join

Age: 30 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

1. Subjects must have completed RC-002.
2. Subjects can give appropriate consent.

You may not qualify if…

1. Subjects who require the use of index arm for ambulation or mobilization via wheelchair, walker, crutches or cane.
2. Subjects whose pain behavior or pain medication usage is, in the opinion of the Investigator, out of proportion to the underlying clinical condition or could interfere with the study-required assessments.
3. Subject is on an active regimen of chemotherapy or radiation-based treatment.
4. Subject is part of a vulnerable population who, in the judgment of the Investigator, is unable to give informed consent for reasons of incapacity, immaturity, adverse personal circumstances or lack of autonomy. This may include individuals with a mental disability, persons in nursing homes, children, impoverished persons, persons in emergency situations, homeless persons, nomads, refugees, and those incapable of giving informed consent. Vulnerable populations also may include members of a group with a hierarchical structure such as university students, subordinate hospital and laboratory personnel, employees of the Sponsor, members of the armed forces, and persons kept in detention.
5. Uncooperative subjects or those with neurological/psychiatric disorders who are incapable of following directions or who are predictably unwilling to return for follow-up examinations.

Where it is running

Arizona Research Center — Phoenix, Arizona, United States
Biosolutions Clinical Research Center — La Mesa, California, United States
Lotus Clinical Research, LLC — Pasadena, California, United States
Sports and Orthopedic Center — Coral Springs, Florida, United States
Universal Axon Clinical Research — Doral, Florida, United States
Andrews Institute for Orthopedics and Sports Medicine — Gulf Breeze, Florida, United States
Georgia Institute for Clinical Research — Marietta, Georgia, United States
Tulane University School of Medicine — New Orleans, Louisiana, United States
Sanford Orthopedic Clinic/Research — Sioux Falls, South Dakota, United States
HD Research — Houston, Texas, United States
Texas Center for Cell Therapy and Research — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.